Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection

COVID-19 can trigger a systemic inflammatory response that in some cases leads to severe lung involvement, multisystem dysfunction, and death. Dexamethasone therapy, because of its potent anti-inflammatory effects, has been proposed for the management of hospitalized patients with severe COVID-19. T...

Descripción completa

Detalles Bibliográficos
Autor principal: Olivera, Mario J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Perspective Pieces
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103443/
https://www.ncbi.nlm.nih.gov/pubmed/33720844
http://dx.doi.org/10.4269/ajtmh.20-1085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103443/
https://www.ncbi.nlm.nih.gov/pubmed/33720844
http://dx.doi.org/10.4269/ajtmh.20-1085

Ejemplares similares